Welcome to LookChem.com Sign In|Join Free

CAS

  • or

67319-76-0

Post Buying Request

67319-76-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

67319-76-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 67319-76-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,3,1 and 9 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 67319-76:
(7*6)+(6*7)+(5*3)+(4*1)+(3*9)+(2*7)+(1*6)=150
150 % 10 = 0
So 67319-76-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H13N3/c8-3-1-2-5-10-6-4-9-7-10/h4,6-7H,1-3,5,8H2

67319-76-0Relevant articles and documents

MODULATORS OF STIMULATOR OF INTERFERON GENES (STING)

-

Page/Page column 59, (2020/01/08)

The present invention relates to compounds of formula (I) and salts, stereoisomers, tautomers or N-oxides thereof that are useful as modulators of STING (Stimulator of Interferon Genes). The present invention further relates to the compounds of formula (I) for use as a medicament and to a pharmaceutical composition comprising said compounds.

The first potent inhibitors for human glutaminyl cyclase: Synthesis and structure-activity relationship

Buchholz, Mirko,Heiser, Ulrich,Schilling, Stephan,Niestroj, André J.,Zunkel, Katrin,Demuth, Hans-Ulrich

, p. 664 - 677 (2007/10/03)

The first effective inhibitors for human glutaminyl cyclase (QC) are described. The structures are developed by applying a ligand-based optimization approach starting from imidazole. Screening of derivatives of that heterocycle led to compounds of the imidazol-1-yl-alkyl thiourea type as a lead scaffold. A library of thiourea derivatives was synthesized, resulting in an inhibitory improvement by 2 orders of magnitude, leading to 1-(3-(1H-imidazol-1-yl)propyl)- 3-(3,4-dimethoxyphenyl)thiourea as a potent inhibitor. Systematic exploitation of the scaffold revealed a strong impact on the inhibitory efficacy and resulted in the development of imidazole-propyl-thioamides as another new class of potent inhibitors. A flexible alignment of the most potent compounds of the thioamide and thiourea class and a QC substrate revealed a good match of characteristic features of the molecules, which suggests a similar binding mode of both inhibitors and the substrate to the active site of QC.

2-heteroaryl-alkyl-1H-benz[de]-isoquinoline-1,3(2H)-diones

-

, (2008/06/13)

This invention concerns novel 2-heteroarylalkyl-1H-benz[de]isoquinoline-1,3(2H)-diones which are useful as inhibitors of thromboxane synthetase and/or as hypotensive agents in the treatment of hypertension and myocardial ischemia.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 67319-76-0